These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7608429)

  • 1. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.
    Gurfinkel EP; Manos EJ; Mejaíl RI; Cerdá MA; Duronto EA; García CN; Daroca AM; Mautner B
    J Am Coll Cardiol; 1995 Aug; 26(2):313-8. PubMed ID: 7608429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina.
    Holdright D; Patel D; Cunningham D; Thomas R; Hubbard W; Hendry G; Sutton G; Fox K
    J Am Coll Cardiol; 1994 Jul; 24(1):39-45. PubMed ID: 8006281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin.
    Gurfinkel EP; Santopinto J; Bozovich GE; Quispe A; Strinna A; Mautner B
    Am Heart J; 2000 Jul; 140(1):E12-8. PubMed ID: 10874258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
    Oler A; Whooley MA; Oler J; Grady D
    JAMA; 1996 Sep; 276(10):811-5. PubMed ID: 8769591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a very low molecular weight heparin compared with standard heparin in patients with unstable angina: a pilot study.
    Mattioli AV; Castellani ET; Goedecke L; Sormani L; Sternieri S; Mattioli G
    Clin Cardiol; 1999 Mar; 22(3):213-7. PubMed ID: 10084064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of thrombolysis versus heparin in unstable angina.
    Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
    Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Adams PC; Parry G; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Chesebro JH; Strain J; Keller C
    Circulation; 1994 Jan; 89(1):81-8. PubMed ID: 8281698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
    N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
    Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
    Cohen M; Théroux P; Borzak S; Frey MJ; White HD; Van Mieghem W; Senatore F; Lis J; Mukherjee R; Harris K; Bigonzi F;
    Am Heart J; 2002 Sep; 144(3):470-7. PubMed ID: 12228784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group.
    Neri Serneri GG; Modesti PA; Gensini GF; Branzi A; Melandri G; Poggesi L; Rostagno C; Tamburini C; Carnovali M; Magnani B
    Lancet; 1995 May; 345(8959):1201-4. PubMed ID: 7739307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.